Banish manufactures a revolutionary lotion to prevent and treat cold sore outbreaks.
Business Model: B2C
Revenue: $0
Employees: 11-50
Address:
City:
State:
Zip:
Country:
Banish, by Sean Moore, has recently completed market testing of a new treatment for the common cold sore virus. The unique blend of active ingredients and excipients has resulted in a strong value proposition whereby 93% of trial users claimed Banish heals cold sore outbreaks faster than any other product they have used in the past. Banish is about to undergo evaluation from the Therapeutic Goods Administration in order to fully commercialise.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2017 | Non Equity Assistance | 1 | - |
Pitch@Palace Pitch@Palace |
10/2017 | Non Equity Assistance | 1 | - |
Pitch@Palace Pitch@Palace |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|